Nmda Treatment
Nmda Treatment - Related Videos
06:42
Application of a NMDA Receptor Conductance in Rat Midbrain Dopaminergic Neurons Using the Dynamic Clamp Technique
0 Views •
Cited by 5 •
2010
In this video, we demonstrate how to apply a conductance into a dopaminergic neuron recorded in the whole cell configuration in rat brain slices. This technique is called the dynamic clamp.
07:11
Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity
0 Views •
2025
Here, we describe the use of a genetically directed alkaline phosphatase (AP) labeling method to investigate the anatomical features and phenotypes of mouse retinas under NMDA-induced excitotoxicity. In conjunction with several retinal ganglion cell (RGC) subtype-specific reporter lines, we uncover novel phenotypes in dying RGCs throughout the degenerative process.
01:30
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
0 Views •
2024
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
0 Views •
Cited by 26 •
2013
Psoriasis is a chronic, immune-mediated inflammatory skin disease. The Goeckerman regimen, formulated for the treatment of psoriasis, consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). The following protocol is for the administration of Goeckerman therapy for the treatment of moderate-to-severe psoriasis.
04:48
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
0 Views •
Cited by 1 •
2018
The goal of this protocol is to facilitate the study of NMDA-receptors (NMDAR) at a larger scale and allow the examination of modulatory effects of small molecules and their therapeutic applications.
FAQs
NMDA treatment can alter signaling by reducing or modifying receptor activity rather than simply eliminating NMDA receptor function. Antagonists may limit excessive calcium entry and the downstream excitotoxic signaling associated with overactivation. Because these receptors participate in synaptic signaling, learning, and memory, the intended effect is a context-dependent adjustment of neuronal excitability, not a uniform shutdown of brain communication.
The magnesium block makes receptor activation dependent on both ligand binding and membrane voltage. Glutamate and glycine binding alone does not fully describe the opening process; membrane depolarization must also relieve the block. This coupling allows NMDA receptors to link chemical synaptic signals with electrical activity, a feature central to their neuroscience relevance.
Limiting excessive calcium influx can reduce downstream excitotoxic signaling, which is why receptor antagonism is investigated in settings where overactivation may be harmful. However, calcium entry is also part of normal NMDA receptor signaling. The relevant scientific issue is therefore balance: treatment must modify excessive activity while preserving the receptor’s contribution to synaptic communication and related functions.
Different responses can arise because NMDA-targeting effects depend on receptor distribution, dose, and clinical setting. Receptor distribution influences which neural circuits are affected, while dose changes the degree of receptor modification. The surrounding treatment context also matters, so findings from one disease, experiment, or clinical use should not automatically be generalized to another.
NMDA-targeting drugs are relevant to several distinct areas: neurodegenerative disease, pain, anesthesia, and treatment-resistant depression. Memantine and ketamine-related therapies are examples identified in this context, but the overview does not imply identical use or effects for each. Their roles may be therapeutic or investigational depending on the condition and clinical setting.
Evaluation should connect the intervention to changes in receptor activity, calcium influx, excitotoxic signaling, and neuronal excitability, while also recording the dose and setting. Interpreting learning, memory, or synaptic outcomes requires attention to the receptor’s normal signaling role. This framework helps distinguish beneficial modification from excessive suppression.